Ozi bụ isi
Aha ngwaahịa | Katalọgụ | Ụdị | Onye ọbịa/Isi iyi | Ojiji | Ngwa | Epitope | COA |
HTLV Antigen | BMGTLV001 | Antigen | E.coli | Were | LF, IFA, IB, WB | I-gp21+gp46;II-gp46 | Budata |
HTLV Antigen | BMGTV002 | Antigen | E.coli | Conjugate | LF, IFA, IB, WB | I-gp21+gp46;II-gp46 | Budata |
HTLV Antigen | BMGTLV241 | Antigen | E.coli | Were | LF, IFA, IB, WB | P24 protein | Budata |
HTLV Antigen | BMGTLV242 | Antigen | E.coli | Conjugate | LF, IFA, IB, WB | P24 protein | Budata |
HTLV - Enwere ike ibunye m site na mmịnye ọbara, ịgba ọgwụ mgbochi ma ọ bụ mmekọ nwoke na nwanyị, a pụkwara ibunye m n'ụzọ kwụ ọtọ site na placenta, ebe ọmụmụ ma ọ bụ lactation.Ọrịa leukemia T-lymphocyte okenye kpatara HTLV – Ⅰ na-efe efe na Caribbean, ugwu ọwụwa anyanwụ South America, ndịda ọdịda anyanwụ Japan na mpaghara ụfọdụ dị n'Africa.China achọpụtala ikpe ole na ole n'akụkụ ụfọdụ dị n'ụsọ osimiri.Ọrịa HTLV – Ⅰ na-abụkarị asymptomatic, mana ohere nke onye bu ọrịa ahụ na-etolite n'ime okenye T-lymphocyte leukemia bụ 1/20.Mmụba dị njọ nke mkpụrụ ndụ CD4+T nwere ike ịdị nnukwu ma ọ bụ na-adịghị ala ala, yana ngosipụta ụlọ ọgwụ nke ọnụ ọgụgụ lymphocyte dị oke njọ, lymphadenopathy, hepatosplenomegaly, na mmebi akpụkpọ anụ dị ka ntụpọ, papular nodules, na exfoliative dermatitis.
Ankylosing ala ụkwụ paresis bụ ụdị nke abụọ nke ọrịa metụtara HTLV – Ⅰ ọrịa.Ọ bụ nsogbu sistemu ụjọ na-aga n'ihu nke na-adịghị ala ala, nke e ji adịghị ike, adịghị ike, azụ azụ nke akụkụ ụkwụ abụọ nke ala, na mgbakasị eriri afọ.N'ụfọdụ ndị mmadụ, ọnụọgụ ọrịa HTLV – Ⅱ dị elu, dị ka ịgbanye ndị na-aṅụ ọgwụ.